Workhorse Group Receives HVIP Approval from California Air Resources Board for the W56
CINCINNATI, Jan. 03, 2024 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company […]
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief
TEL AVIV, Israel, Jan. 03, 2024 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company“), a clinical-stage specialty […]
Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)
Multinational operator has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products. Clever Leaves is […]
Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BEDFORD, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to […]
Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed […]
CEMATRIX Announces $6.2 Million Increase in Contracts
CALGARY, Alberta, Jan. 03, 2024 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company“) a North […]
Safe & Green Holdings CEO Provides Letter to Shareholders
Safe & Green Holdings’ Modular Manufacturing Facility MIAMI, Jan. 03, 2024 (GLOBE NEWSWIRE) — Safe & Green Holdings Corp. (NASDAQ: […]
Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals’ Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment
HOUSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) announces that the hematologic cancer Phase 1/2 clinical […]
Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that […]
NewtekOne, Inc. Announces Record Loan Closings for the Fourth Quarter and Full Year 2023
BOCA RATON, Fla., Jan. 03, 2024 (GLOBE NEWSWIRE) — NewtekOne, Inc. (the “Company” or “NewtekOne”) (NASDAQ: NEWT), announced today that […]
